AzTrials
AzTrials

StrokeNCT06140316

Biopsychosocial and Motor Predictor of Functional Recovery in Stroke Survivors

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Up to the researcher knowledge, there is currently limited literature available that thoroughly investigates the biopsychosocial and motor predictors of functional recovery in stroke survivors. Read more about this study

Who is it for?
Ages 45 to 65 years
Conditions the study is for
Stroke
How many people
104 participants
Where
1 sitePakistan
Study dates
15 Nov 2023to 10 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Study Design: The study design is a prospective cohort study, where a group of participants will be followed over time to observe changes in patient outcomes after receiving physiotherapy interventions. Study Setting: Data for this study will be collected from the Dera Ghazi Khan Teaching Hospital and the affiliated physiotherapy center. Study Duration: The study will span a period of six months, commencing after receiving approval from the Bioethical Review Board (BASR). Sample Size: The study will include a total of 104 participants.

Who may be able to join

  • Either gender
  • Patients with age between 45 to 65 years.
  • Ischemic stroke patients
  • Patients having stroke from 3 to 7 days at the time of recruitment

Who cannot join

  • Patients with previous stroke history
  • Presence or history of intracranial tumor, with/without tumor bleeding.
  • Presence or history of traumatic brain injury.
  • Presence or history of encephalopathy/myelopathy.
  • Presence or history of central nervous system infection/ inflammation.
  • Presence or history of degenerative central or peripheral nervous system disease, including neuropathy, neuronopathy, or myopathy

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • DHQ Dera Ghazi Khan

    Dera Ghazi Khan, Punjab Province, 32200

Other trials in Pakistan

About this study

Official title: Biopsychosocial and Motor Predictor of Functional Recovery in Stroke Survivors, A Prospective Cohort

Up to the researcher knowledge, there is currently limited literature available that thoroughly investigates the biopsychosocial and motor predictors of functional recovery in stroke survivors. Previous studies have only focused on examining these factors individually, without considering their collective impact on functional outcomes. As a result, there is a significant research gap in understanding how these factors interact and influence the recovery process. By integrating the biopsychosocial model with motor predictors, this study will provide a unique and comprehensive perspective on the recovery trajectory of stroke survivors.

Read the detailed description

Stroke is a leading cause of impairment, with 20% of survivors requiring institutional care for 3 months afterward, and 15% to 30% being disabled permanently. A review in 2016 has shown that over the past four decades, a statistically significant trend in stroke incidence rate declined in high-income countries (42%) but in low- to middle-income countries, it was increasing to a greater than 100% trend over time. Functional recovery after a stroke is a complex and multifactorial process influenced by a combination of biopsychosocial and motor factors. Biopsychosocial factors encompass the interplay between biological, psychological, and social aspects of an individual's life that can influence their recovery trajectory. Motor factors, on the other hand, specifically focus on impairments and functional limitations related to movement and mobility. Only a few studies have explored the role of various biopsychosocial and motor factors in predicting functional recovery in stroke survivors and these studies have focused on the factors individually. Biologically, factors such as lesion location, stroke severity, age, and comorbidities have been shown to influence recovery outcomes. Psychologically, factors like motivation, self-efficacy, depression, and cognitive function can significantly impact a person's ability to engage in rehabilitation and regain functional abilities. Social factors, including social support, access to rehabilitation services, and socioeconomic status also play a critical role in facilitating or hindering recovery.

Likewise, motor factors, such as motor impairment, balance, gait, speed, and functional mobility are strong predictors of functional recovery. Motor recovery is closely associated with the reorganization of neural pathways and the restoration of motor function. Up to the researcher knowledge, there is currently limited literature available that thoroughly investigates the biopsychosocial and motor predictors of functional recovery in stroke survivors. Previous studies have only focused on examining these factors individually, without considering their collective impact on functional outcomes. As a result, there is a significant research gap in understanding how these factors interact and influence the recovery process.

Conditions
Stroke
Keywords
Biopsychosocial, Functional recovery, Motor predictors, Stroke
Medical subject headings
Stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Ambulatory Classification

    A classification system that categorizes individuals based on their level of functional ambulation, ranging from non-ambulatory to fully independent ambulation.

    Measured: 8 weeks

  2. Fugl-Meyer Assessment

    A standardized assessment that evaluates the motor function and recovery of the lower limbs and upper limb, including voluntary movement, reflex activity, coordination, and balance.

    Measured: 8 weeks

  3. Mini-Balance Evaluation Systems Test

    A clinical tool that assesses balance impairments by evaluating various components of balance control, including anticipatory postural adjustments, reactive postural responses, sensory orientation, and stability during gait.

    Measured: 8 weeks

  4. Modified Barthel Index

    A widely used functional assessment tool that measures a person's ability to perform activities of daily living (ADLs) independently, including self-care tasks such as bathing, dressing, and toileting

    Measured: 8 weeks

  5. Hospital Anxiety and Depression Scale

    A self-report questionnaire designed to assess symptoms of anxiety and depression in individuals with physical health conditions, providing a measure of emotional well-being and psychological distress.

    Measured: 8 weeks

  6. National Institute of health Stroke Scale

    The NIH Stroke Scale (NIHSS) is a widely used tool to assess and measure the severity of neurological deficits after a stroke.

    Measured: 8 weeks

  7. Motricity Score

    The Motricity Scale is a standardized assessment tool designed to evaluate motor function and strength in individuals with stroke.

    Measured: 8 weeks

  8. Modified Ashworth Scale

    The Modified Ashworth Scale (MAS) is a commonly used clinical assessment tool to measure spasticity in individuals with neurological conditions.

    Measured: 8 weeks

  9. Trunk Control test

    The trunk control test is a clinical assessment that evaluates the stability and control of the core region of the body, helping determine functional abilities and guide rehabilitation interventions.

    Measured: 8 weeks

  10. Functional Independence Measure

    The Functional Independence Measure (FIM) is a standardized assessment tool that measures a person's level of independence in daily activities.

    Measured: 8 weeks

  11. Recovery Locus of Control Scale

    The Recovery Locus of Control Scale is a psychometric tool used to assess an individual's perception of control over their own recovery process. It

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2023
  2. Study start15 Nov 2023
  3. Primary completion10 Apr 2024
  4. Study completion10 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06140316
Sponsor's protocol ID
REC/0243 Aniqa Nasreen
Status last verified
May 2024
First submitted
15 Nov 2023
Last updated
7 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Ambulatory Classification (time frame: 8 weeks). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in